TMDX · TransMedics Group, Inc.
$88.58
-1.06 (-1.18%)
At close · Aug 14
Market Cap
$3.07B
Shares
34.68M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-08-11 | 2026-09-30 | |
| 10-Q | 2026-08-04 | 2026-06-30 | |
| 8-K | 2026-08-04 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-05-21 | 2026-05-20 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-10 | 2026-05-20 | |
| 8-K | 2026-02-27 | — | |
| 8-K | 2026-02-24 | — | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-02-04 | 2026-02-01 | |
| 8-K | 2026-01-12 | 2026-01-08 | |
| 10-Q | 2025-10-29 | 2025-09-30 | |
| 8-K | 2025-10-29 | — | |
| 8-K | 2025-10-06 | 2025-10-03 | |
| 10-Q | 2025-07-30 | 2025-06-30 | |
| 8-K | 2025-07-30 | — | |
| 8-K | 2025-05-23 | 2025-05-22 | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-10 | 2025-05-22 | |
| 8-K | 2025-02-27 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-21 | 2025-02-20 | |
| 8-K | 2025-01-14 | 2025-01-08 | |
| 8-K | 2024-12-09 | 2024-12-05 | |
| 8-K | 2024-12-02 | 2024-11-26 | |
| 10-Q | 2024-10-29 | 2024-09-30 | |
| 8-K | 2024-10-28 | — | |
| 8-K | 2024-09-11 | 2024-09-06 | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-07-31 | — | |
| 8-K | 2024-07-29 | 2024-07-26 | |
| 8-K | 2024-07-02 | 2024-06-27 | |
| 8-K | 2024-05-28 | 2024-05-23 | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| 8-K | 2024-04-30 | — | |
| DEF 14A | 2024-04-10 | 2024-05-23 | |
| 8-K | 2024-03-12 | 2024-03-08 | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-02-26 | — | |
| 8-K | 2024-02-06 | 2024-02-02 | |
| 8-K | 2024-01-29 | 2024-01-25 | |
| 8-K | 2024-01-02 | 2023-12-29 | |
| 8-K | 2023-12-19 | 2023-12-18 | |
| 8-K | 2023-11-13 | 2023-11-09 | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 8-K | 2023-11-06 | — | |
| 8-K | 2023-09-22 | 2023-09-21 |
Showing 1–50 of 115 filings
Key facts
CIK
1756262
CUSIP
89377M109
13F (30d)
352 filings
348 filers
Visit website
Investor relations